期刊文献+

肝细胞基因转导载体系统应用进展 被引量:3

The Advances of Hepatocyte-Directed Gene Transfer Vectors
暂未订购
导出
摘要 目的 探讨稳定、高效、低毒的基因转导载体系统在基础研究和临床应用中的重要意义。方法 采用文献回顾的方法并结合当前实验研究 ,对肝细胞基因转导载体系统的研究和应用进展加以综述。结果 病毒载体系统和非病毒载体系统均可实现目的基因对肝细胞的有效转导 ,转导效率因各载体系统生物学特性不同而各异。结论 肝细胞是基因治疗有效的靶细胞 ,多种与肝脏相关的遗传性疾病、恶性肿瘤、感染性疾病等均可实现靶基因的有效转导 。 Objective To investigate the stable, high effective and low toxicity gene transfer vectors' basics in research and clinical application.Methods Current status of hepatocyte directed gene transfer vectors were reviewed by history document and contemporary experimental advances analysis.Results Viral and nonviral vector systems could both transduce target genes to liver effectively with various transduction rates based on their corresponding biological characteristics.Conclusion Hepatocyte is the effective target for gene therapy of liver related genetic, neoplastic and infectious diseases, although the security needs to be further evaluated.
作者 代文杰
出处 《中国普外基础与临床杂志》 CAS 2002年第1期58-60,共3页 Chinese Journal of Bases and Clinics In General Surgery
关键词 肝细胞 基因治疗 基因转导载体 临床应用 Hepatocyte Gene therapy Gene transfer vector
  • 相关文献

参考文献21

  • 1[1]Ferry N, Heard JM. Liver-directed gene transfer vectors [J]. Hum Gene Ther, 1998; 9(9)∶1975
  • 2[2]Grossman M, Rader DJ, Muler DWM, et al. A pilot study of ex vivo gene therapy for homozygous familial hypercholesterolemia [J]. Nature Med, 1995; 1(10)∶1148
  • 3[3]Kitten O, Cosset FL, Ferry N. Highly efficient retrovirus-mediated gene transfer into rat hepatocytes in vivo [J]. Hum Gene Ther, 1997; 8(7)∶1491
  • 4[4]Tada K, Chowdhury NR, Neufeld D, et al. Long-term reduction of serum bilirubin levels in Gunn rats by retroviral gene transfer in vivo [J]. Liver Tansplant Surg, 1998; 4(1)∶ 78
  • 5[5]Shiraishi M, Tomori H, Nagahama M, et al. Stable gene expression with VSV-G pseudotyped-retrovirus vector in the rat liver [J]. J Surg Res, 1999; 84(1)∶168
  • 6[6]Jooss K, Yang Y, Wilson JM.Cyclophosphamide diminishes inflammation and prolongs transgene expression following delivery of adenoviral vectors to mouse liver and lung [J]. Hum Gene Ther, 1996; 7(8)∶1555
  • 7[7]Kay MA, Meuse L, Gown AM, et al. Transient immunomodulation with anti-CD40 ligand antibody and CTLA4-Ig enhances persistence and secondary adenovirus-mediated gene transfer into mouse liver [J]. Proc Natl Acad Sci USA, 1997; 94(8)∶4686
  • 8[8]Ilan Y, Attavar P, Takahashi M, et al. Induction of central tolerance by intrathymic inoculation of adenoviral antigens into the host thymus permits long-term gene therapy in Gunn rats [J]. J Clin Invest, 1996; 98(10)∶2640
  • 9[9]Wang Q, Greenburg G, Bunch D, et al. Persistent transgene expression in mouse liver following in vivo gene transfer with a delta E1/delta E4 adenovirus vector [J]. Gene Ther, 1997; 42)∶393
  • 10[10]Dedieu JF, Vigne E, Torrent C, et al. Long-term gene delivery into the livers of immunocompetent mice with E1/E4-defective adenoviruses [J]. J Virol, 1997; 71(5)∶4626

同被引文献57

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部